# Tegafur-Gimeracil-Oteracil K

## TS-1 20mg

| 藥物代碼 | OTS1 |
| :--- | :--- |
| 適應症 | Post-op adjuvant chemotherapy for locally advanced \[stage II \(excluding T1\), IIIA or IIIB\) gastric cancer.Treatment for advanced Inoperable or recurrent gastric cancer. |
| 副作用 | Leukopenia, decreased Hb, thrombocytopenia, decreased neutrophil count; increased AST/ALT, bilirubin & creatinine; glycosuria, stomatitis, anorexia, nausea, vomiting, diarrhea, abdominal pain, constipation, rash, pigmentation, lacrimation, taste abnormality, dizziness, decreased weight, pyrexia, nasopharyngitis & fatigue. |
| 禁忌 | Severe bone marrow depression, renal & hepatic disorder. Treatment with other fluoropyrimidine-group anticancer drugs \(including combination therapies\) & flucytosine. Pregnancy & lactation. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Adult =1.5 m2 BSA Initially 60 mg. All doses are to be taken bid, for 28 consecutive days followed by a 14-day rest. |
| 肝功能異常 | 無需調整劑量  肝功能障礙脂患者應警慎投與 嚴重肝功能障礙患者不建議使用 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 不可使用 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Hold Breast Feeding 暫停哺乳 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

